Clinic Treatment in PA for COPD

What is Chronic Obstructive Pulmonary Disease (COPD)?

Chronic obstructive pulmonary disease (COPD) is a progressive form of lung disease ranging from mild to severe. It is characterized by a restriction of airflow into and out of the lungs that makes breathing difficult. COPD is the umbrella term for sufferers who have been diagnosed with or show signs of emphysema and/or chronic bronchitis. In Pittsburgh, COPD is a health concern for many, in part due to air pollution levels and occupational hazards. In 2015, the Lung Institute will open a clinic treatment in PA for COPD.

COPD in Pennsylvania

Unfortunately many Pennsylvania residents suffer from chronic obstructive pulmonary disease (COPD). When diagnosed with COPD, a person might feel overwhelmed or hopeless because, unfortunately, COPD cannot be cured. Things like medications, inhalers and oxygen therapy help lessen the symptoms of COPD.  There is a relatively new stem cell treatment that has been very effective for many patients. The stem cell treatment is a minimally invasive procedure that harnesses the body’s own healing properties. The Lung Institute specializes in treating patients with debilitating lung disease with stem cell therapy.

What is Stem Cell Therapy for COPD?

Stem cell therapy harnesses the body’s natural healing capabilities to expedite the healing process. At the Lung Institute, the stem cell procedure is a three day outpatient treatment, where stem cells are extracted from a person’s blood, fat tissue or bone marrow. After the cells have been extracted, they are treated in a lab on site and then reintroduced into the body directly into the damaged tissue areas. Stem cells are how your body heals itself after getting a cut or bruise, however, sometimes this healing process can move more slowly than the disease progresses, like in the case of lung disease. By targeting many stem cells directly onto the damaged tissue, the body has the opportunity to heal itself more quickly. In most cases this results in stopping the progression of the disease or even improved lung function.

About the Staff

Dr. Jack Coleman, Jr., MD, will be the Medical Director of the Pittsburgh clinic. Dr. Coleman earned his medical degree from the University of Cincinnati. He later became an otolaryngology resident at the University of Pittsburgh Eye and Ear Hospital. He also served as a Lieutenant Commander and Commander in the United States Naval Reserve. Dr. Coleman is a diplomat of the National Board of Medical Examiners, is Board Certified in Otolaryngology and is a Fellow of the American Academy of Otolaryngology and Head and Neck Surgery. He is also a member of numerous medical societies including the American Medical Association, American Rhinologic Society, Association of Military Surgeons of the United States and the Pan-American Society of Otolaryngology. Along with his distinguished medical career, Dr. Coleman is a published author for several medical books and is referenced in numerous medical journals.

Dr. Coleman and the Lung Institute look forward to being able to treat more patients by opening a fourth clinic in Pittsburgh. The clinic will open July 13, 2015 and the ribbon cutting ceremony will be attended by medical staff, the Lung Institute’s corporate team members and local Pittsburgh Chamber of Commerce Members.

At least 70 percent of Lung Institute patients have reported a better quality of life after undergoing stem cell therapy for COPD. For many who suffer from COPD in Pennsylvania, the Lung Institute might be the answer. If you or a loved one suffers from a lung disease like COPD, contact one of our patient coordinators today at (800) 729-3065 to see if you qualify.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.